购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

SNS-314 Mesylate

Rating icon 还可以
产品编号 T2617Cas号 1146618-41-8
别名 SNS-314

SNS-314 Mesylate (SNS-314) 是一种有效且特异性的极光激酶抑制剂,对极光激酶 A、B、C 的 IC50值分别为 9,31 和 3 nM。

SNS-314 Mesylate

SNS-314 Mesylate

Rating icon 还可以
纯度: 99.92%
产品编号 T2617 别名 SNS-314Cas号 1146618-41-8

SNS-314 Mesylate (SNS-314) 是一种有效且特异性的极光激酶抑制剂,对极光激酶 A、B、C 的 IC50值分别为 9,31 和 3 nM。

规格价格库存数量
1 mg¥ 247现货
2 mg¥ 352现货
5 mg¥ 579现货
10 mg¥ 892现货
25 mg¥ 1,820现货
50 mg¥ 2,650现货
100 mg¥ 4,130现货
500 mg¥ 8,750期货
1 mL x 10 mM (in DMSO)¥ 668现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"SNS-314 Mesylate"的相关化合物库

选择批次:
纯度:99.92%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
SNS-314 Mesylate (SNS-314) is an effective and specific Aurora A/B/C inhibitor (IC50: 9/31/3 nM). It is less inhibition of Trk A/B, Fms, Flt4, c-Raf, Axl, and DDR2.
靶点活性
Aurora C:3 nM, Aurora A:9 nM, Aurora B:31 nM
体外活性
在HCT116 结肠移植瘤中,SNS-314的抗癌效果明显和持久.在人类乳腺癌,前列腺癌,肺癌(H1299和Calu-6),卵巢癌及恶性黑色素瘤的鼠移植瘤中,SNS-314(170 mg/kg)对肿瘤生长抑制率为54-91%.
体内活性
用SNS-314和吉西他滨、卡铂、道诺霉素、氟尿嘧啶和SN-38连续处理使抗增殖效果加强,SNS-314和吉西他滨,多西他赛,或长春新碱联用有协同效果。SNS-314对肿瘤细胞系具有明显抑制作用(IC50:1.8-24 nM), 且不依赖于Aurora-A或Aurora-B的相对蛋白水平。
激酶实验
Aurora-A Kinase Assay: Humanized mouse Aurora A (amino acids 107-403) is expressed in E. coli as described previously. For IC50 assays, compounds are titrated three-fold in DMSO and diluted 12.5-fold into assay buffer (10 mM Tris HCl pH 7.2, 10 mM MgCl2, 0.05% NaN3, 0.01% Tween-20, and 0.1% BSA). Compounds are then diluted 4-fold into assay buffer containing Aurora A and FAM-PKAtide at final concentrations of 2 nM and 50 nM, respectively. The kinase reaction is initiated by adding ATP in assay buffer at a final concentration of 10 mM and incubated at 21 °C for 25 minutes. As a positive control, DMSO is added instead of compound and as a negative control assay buffer is added instead of Aurora A. Both control reactions are conducted in triplicate. To detect phosphorylated PKAtide, the kinase reaction is combined with Progressive Binding Solution (1:400 Progressive Binding Reagent, 1 × Buffer A, Molecular Devices) in a 1:3 ratio. The mixture is incubated for 30 minutes at 21 °C and the plate is scanned on an Analyst AD with excitation at 485 nm and emission at 530 nm. The percent relative enzymatic activity is calculated by normalizing the mP value for each well to the average positive control. Relative enzymatic activity values are plotted as a function of the logarithm of compound concentration and IC50 values are generated in GraphPad Prism software using a sigmoidal dose-response curve-fit. IC50's are calculated as the concentration of compound at which enzymatic activity i
细胞实验
Viability is measured using the CellTiter-Blue cell viability assay. Cells are treated as described above, although with a 5-day incubation period. Cytotoxicity is determined by measuring intracellular ATP using the CellTiter-Glo Luminescence Cell Viability Assay. Cells are seeded in white 96-well tissue culture plates at a density of 1.5-2 × 103 cells/well, and a serial dilution of SNS-314 is dosed in combination with fixed concentrations of either docetaxel or vincristine for a total of 72 hours. Viability is determined as the ratio between the ATP in treated cells versus control cells. Apoptosis is measured using the caspase-Glo 3/7 system. Cells are plated in white 96-well plates as described above and treated first with SNS-314 for 24 hours, washed with 200 μL of 1× PBS, and fresh medium is added with the second agent for 24 hours.(Only for Reference)
别名SNS-314
化学信息
分子量527.04
分子式C18H15ClN6OS2·CH4O3S
CAS No.1146618-41-8
SmilesCS(O)(=O)=O.Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1
密度no data available
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 52.7 mg/mL (100 mM)
溶液配制表
1mg5mg10mg50mg
1 mM1.8974 mL9.4869 mL18.9739 mL94.8695 mL
5 mM0.3795 mL1.8974 mL3.7948 mL18.9739 mL
10 mM0.1897 mL0.9487 mL1.8974 mL9.4869 mL
20 mM0.0949 mL0.4743 mL0.9487 mL4.7435 mL
50 mM0.0379 mL0.1897 mL0.3795 mL1.8974 mL
100 mM0.0190 mL0.0949 mL0.1897 mL0.9487 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy SNS-314 Mesylate | purchase SNS-314 Mesylate | SNS-314 Mesylate cost | order SNS-314 Mesylate | SNS-314 Mesylate chemical structure | SNS-314 Mesylate in vivo | SNS-314 Mesylate in vitro | SNS-314 Mesylate formula | SNS-314 Mesylate molecular weight